Label: RIBAVIRIN tablet, film coated
-
NDC Code(s):
65841-046-03,
65841-046-10,
65841-046-28,
65841-046-77, view more65841-129-07, 65841-129-14, 65841-129-17, 65841-603-07, 65841-603-14, 65841-603-17, 65841-632-07, 65841-632-14, 65841-632-17
- Packager: Zydus Lifesciences Limited
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated December 4, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Medication Guide: HTML
- Official Label (Printer Friendly)
- MEDICATION GUIDE
- SPL MEDGUIDE
-
PRINCIPAL DISPLAY PANEL
NDC 65841-046-03 in bottle of 168 tablets
Ribavirin Tablets , 200 mg
Rx only
168 tablets
NDC 65841-603-07 in bottle of 56 tablets
Ribavirin Tablets , 400 mg
Rx only
56 tablets
NDC 65841-632-07 in bottle of 56 tablets
Ribavirin Tablets , 500 mg
Rx only
56 tablets
NDC 65841-129-07 in bottle of 56 tablets
Ribavirin Tablets, 600 mg
Rx only
56 tablets
-
INGREDIENTS AND APPEARANCE
RIBAVIRIN
ribavirin tablet, film coatedProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-046 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength RIBAVIRIN (UNII: 49717AWG6K) (RIBAVIRIN - UNII:49717AWG6K) RIBAVIRIN 200 mg Inactive Ingredients Ingredient Name Strength CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) HYPROMELLOSES (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE (UNII: FZ989GH94E) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color PINK (LIGHT PINK TO PINK) Score no score Shape ROUND (ROUND) Size 10mm Flavor Imprint Code ZC19 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-046-03 168 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 2 NDC:65841-046-28 180 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 3 NDC:65841-046-10 1000 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 4 NDC:65841-046-77 10 in 1 CARTON 12/05/2005 4 10 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077094 12/05/2005 RIBAVIRIN
ribavirin tablet, film coatedProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-603 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength RIBAVIRIN (UNII: 49717AWG6K) (RIBAVIRIN - UNII:49717AWG6K) RIBAVIRIN 400 mg Inactive Ingredients Ingredient Name Strength FERRIC OXIDE YELLOW (UNII: EX438O2MRT) HYPROMELLOSES (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE (UNII: FZ989GH94E) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color PINK (LIGHT PINK TO PINK) Score no score Shape OVAL (CAPSULE) Size 17mm Flavor Imprint Code ZD;07 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-603-17 28 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 2 NDC:65841-603-07 56 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 3 NDC:65841-603-14 60 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077094 12/05/2005 RIBAVIRIN
ribavirin tablet, film coatedProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-632 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength RIBAVIRIN (UNII: 49717AWG6K) (RIBAVIRIN - UNII:49717AWG6K) RIBAVIRIN 500 mg Inactive Ingredients Ingredient Name Strength CROSPOVIDONE (UNII: 2S7830E561) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) HYPROMELLOSES (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE (UNII: FZ989GH94E) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color PINK (LIGHT PINK TO PINK) Score no score Shape OVAL (CAPSULE) Size 18mm Flavor Imprint Code ZC56 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-632-17 28 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 2 NDC:65841-632-07 56 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 3 NDC:65841-632-14 60 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077094 12/05/2005 RIBAVIRIN
ribavirin tablet, film coatedProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-129 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength RIBAVIRIN (UNII: 49717AWG6K) (RIBAVIRIN - UNII:49717AWG6K) RIBAVIRIN 600 mg Inactive Ingredients Ingredient Name Strength CROSPOVIDONE (UNII: 2S7830E561) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) HYPROMELLOSES (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE (UNII: FZ989GH94E) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color PINK (LIGHT PINK TO PINK) Score no score Shape OVAL (CAPSULE) Size 21mm Flavor Imprint Code ZD;08 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-129-17 28 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 2 NDC:65841-129-07 56 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 3 NDC:65841-129-14 60 in 1 BOTTLE; Type 0: Not a Combination Product 12/05/2005 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077094 12/05/2005 Labeler - Zydus Lifesciences Limited (918596198) Registrant - Zydus Lifesciences Limited (918596198) Establishment Name Address ID/FEI Business Operations Zydus Lifesciences Limited 918596198 ANALYSIS(65841-046, 65841-603, 65841-632, 65841-129) , MANUFACTURE(65841-046, 65841-603, 65841-632, 65841-129)